Market access

Five tips for the reference price jungle

You need to be familiar with the Finnish reference price system in order to submit price notifications appropriately and on schedule. At worst, forgetting to submit price notification may lead to the medicinal product losing its reimbursability.

› Read more

Pharmaceutical production is not set up overnight

new pharmaceutical production is not set up by clicking fingers. The process is slow and multi-stage, and everything is done in the name of patient safety.

› Read more

Recruiting a MARKET ACCESS TEAM LEADER

We are looking for a MARKET ACCESS TEAM LEADER with a solid experience in strategic and operational market access in the Nordic countries.

› Read more

Familiar with promotional compliance in Sweden?

In Sweden, the person responsible for the company’s marketing activities for medicinal products must have an IMA diploma.

› Read more

New practise: Kela to collect a one-off payback fee from pharmaceutical companies in 2016

This non-recurring payback fee only applies to Kela-reimbursed actual sales.

› Read more